PROCEPT BioRobotics Corp
Closed
SectorHealthcare
20.17 -3.81
Overview
Share price change
24h
Min
20.52
Max
21.24
Income | -27M -58M |
|---|---|
Sales | 11M 94M |
EPS | -0.47 |
Profit margin | -61.905 |
Employees | 888 |
EBITDA | 5.1M -24M |
Next Earnings | 3 lis 2026 |
|---|
Market Cap | 249M 1.3B |
|---|---|
Previous open | 23.98 |
Previous close | 20.17 |
News Sentiment
By Acuity
50%
50%
144 / 339 Ranking in Healthcare
PROCEPT BioRobotics Corp Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
PROCEPT BioRobotics Corp Forecast
Sentiment
By Acuity
144 / 339 Ranking in Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About PROCEPT BioRobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.